Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Dynavax Technologies News

    10,965 € -1,97% -0,22 €
    10:43:05 Uhr Gettex aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A12EV9
    ISIN: US2681582019
    US-Symbol: DVAX
    Typ: Aktie

    Dynavax Technologies News

    27.02.24 - PR Newswire
    Dynavax to Present at TD Cowen's 44th Annual Health Care Conference
    Dynavax to Present at TD Cowen's 44th Annual Health Care Conference PR Newswire
    22.02.24 - PR Newswire
    Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
    Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance PR Newswire
    08.02.24 - PR Newswire
    Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024
    Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024 PR Newswire
    08.01.24 - PR Newswire
    Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
    Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights PR Newswire
    03.01.24 - PR Newswire
    Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire
    20.11.23 - PR Newswire
    Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference
    Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference PR Newswire
    02.11.23 - PR Newswire
    Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
    Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance PR Newswire
    26.10.23 - PR Newswire
    Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023
    Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023 PR Newswire
    19.10.23 - PR Newswire
    Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference
    Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference PR Newswire
    06.09.23 - PR Newswire
    Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference PR Newswire
    03.08.23 - PR Newswire
    Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
    Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance PR Newswire
    20.07.23 - PR Newswire
    Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023
    Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023 PR Newswire
    30.05.23 - PR Newswire
    Dynavax to Present at Upcoming Investor Conferences
    Dynavax to Present at Upcoming Investor Conferences PR Newswire
    08.05.23 - PR Newswire
    Dynavax to Present at the JMP Securities Life Sciences Conference
    Dynavax to Present at the JMP Securities Life Sciences Conference PR Newswire
    02.05.23 - PR Newswire
    Dynavax Reports First Quarter 2023 Financial Results
    Dynavax Reports First Quarter 2023 Financial Results PR Newswire
    18.04.23 - PR Newswire
    Dynavax to Report First Quarter 2023 Financial Results and Host Conference Call on May 2, 2023
    Dynavax to Report First Quarter 2023 Financial Results and Host Conference Call on May 2, 2023 PR Newswire
    01.03.23 - PR Newswire
    Dynavax to Present at the Cowen 43rd Annual Health Care Conference
    Dynavax to Present at the Cowen 43rd Annual Health Care Conference PR Newswire
    28.02.23 - PR Newswire
    Dynavax Announces Great Britain Marketing Authorization for HEPLISAV B®, a Two-Dose Adult Hepatitis B Adjuvanted Vaccine
    Dynavax Announces Great Britain Marketing Authorization for HEPLISAV B®, a Two-Dose Adult Hepatitis B Adjuvanted Vaccine PR Newswire
    23.02.23 - PR Newswire
    Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance
    Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance PR Newswire
    09.02.23 - PR Newswire
    Dynavax to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
    Dynavax to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023 PR Newswire

    Newssuche

    Videos

    newspaper
    09:10 Uhr
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »